ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

Anil Potti Reprimanded by North Carolina Licensure Board

December 9, 2011

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

Congress Funds NIH Through Fiscal Year, Re-Opening Agency With 5.7% Increase

January 12, 1996

Stories On Proscar Cause Confusion In Prostate Cancer Prevention Trial

September 6, 1996

Workshop Suggests Confirmation of Vitamin C Studies

December 7, 1990